The insurance coverage is being evaluated and needs to be assessed by a medical examiner. In Switzerland, since 2007 proton therapy is covered by basic health insurance for the following indications:
- Tumours within in the skull
(chordomas, chondrosarcomas, squamous epthelium carcinomas, adenocarcinomas
and adenocystic carcinomas, lymphoepitheliomas, mucoepidermoid carcinomas,
esthesioneuroblastomas, soft tissue and bone sarcomas, undifferentiated carcinomas,
rare tumours such as paragangliomas).
- Tumours of the brain and the
meninges (grade 1 and 2 gliomas, meningiomas).
- Tumours outside the skull, in
the region of the spine, trunk and extremities (soft tissue and bone sarcoma).
- Paediatric tumours.
Especially those patients, whose tumors can’t be
treated adequately with conventional radiation therapy or whose tumours are located near radio-sensitive
organs or tissues, will immensely profit from ion beam therapy.
Particle therapy is regarded established with the following indications:
Particle therapy is routinely and successfully applied internationally with the following indications:
- Various ENT tumours.
- Lung cancer (localized, central, non-small-cell carcinoma).
- Various mediastinal tumours.
- Left-hand sided breast cancer (with loco regional lymph node metastases).
- Pancreatic carcinoma.
- Hepatocellular carcinoma.
- Various tumours of the pelvis.
- Anal carcinoma.
Protons will be utilized whenever the highest possible precision of dose delivery
is required. This applies to target volumes located very closely to an organ
of risk and/or where surgical intervention is of second choice. This is not related
to special regions of the body.
Please do not hesitate to contact us with your therapy inquiry.